Because the Philadelphia chromosome (Ph+) resulting in the BCR-ABL fusion protein presents a unique disease cause and therapeutic target, chronic myeloid leukemia (CML) is set apart as the only member of Ph+ MPN in the World Health Organization (WHO) classification of MPN. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.